The sequential natalizumab - alemtuzumab therapy in patients with relapsing forms of multiple sclerosis (SUPPRESS) trial - Part I: Rationale and objectives.

Hussain, Rehana Z; Sguigna, Peter V; Okai, Annette; Wright, Crystal; Madinawala, Mariam; Bass, Ann D; Cutter, Gary R; Manouchehri, Navid; Stuve, Olaf

Hussain, Rehana Z; Sguigna, Peter V; Okai, Annette; Wright, Crystal; Madinawala, Mariam; Bass, Ann D; Cutter, Gary R; Manouchehri, Navid; Stuve, Olaf.

Afiliación

Hussain RZ; Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Sguigna PV; Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Okai A; North Texas Institute of Neurology & Headache, Plano, TX, USA.
Wright C; Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Madinawala M; Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Bass AD; Neurology Center of San Antonio, Dallas, TX, USA.
Cutter GR; Department of Biostatistics, Section on Research Methods and Clinical Trials, University of Alabama at Birmingham, Birmingham, AL, USA.
Manouchehri N; Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Stuve O; Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

J Cent Nerv Syst Dis ; 14: 11795735221123911, 2022.

Article en En | MEDLINE | ID: mdl-36062026

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Aspecto: Patient_preference Idioma: En Revista: J Cent Nerv Syst Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google